美国BioForce Nanosciences
BioForce Nanosciences, Inc. develops and commercializes nanotech instruments, consumables and applications for the life sciences. The Company has been providing consumable support products for atomic force microscopy (AFM) for over a decade. In 2005 BioForce introduced its own flagship instrument platform, the Nano eNabler™ system.

The Nano eNabler system is a molecular printer that rapidly and precisely delivers liquids to surfaces such as silicon chips in droplets that are ten billion times smaller than a drop of blood. This unique capability offers researchers in industry and academia a practical solution to problems they encounter when developing ultraminiaturized devices and methods, and creates opportunities for further commercialization of nanotechnology. For example, BioForce’s technology is being used to create biosensors and to study cell biology at the single cell level. Additional applications include printing proteins to guide neural cell growth, printing signaling proteins to study stem cell differentiation, “inking” of micro-stamps for soft lithography, and bio-functionalization of microfluidic devices.

It is through our instrumentation success that we can pursue the third product focus; applications. The patented virus detection chip embodied in the ViriChip™ platform is one such application. The ViriChip technology is designed to be sensitive and specific enough to detect a variety of different pathogens. These could include environmental pathogens (e.g., Noroviruses, coxsackieviruses), pathogens relevant to biodefense (e.g., smallpox, hemorrhagic fever viruses), animal and plant viruses (e.g., foot and mouth disease, rinderpest, Avian influenza, West Nile), and human disease agents (e.g., Human papilloma virus, herpes viruses, SARS).

BioForce Nanosciences, Inc. is a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. (BFNH.OB).